These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30467896)

  • 1. Hepatobiliary and Pancreatic: Pyoderma gangrenosum of the pancreas successfully treated with infliximab.
    Deprez N; Dedeurwaerdere F; Desomer L; De Wulf D
    J Gastroenterol Hepatol; 2019 May; 34(5):816. PubMed ID: 30467896
    [No Abstract]   [Full Text] [Related]  

  • 2. The Final Cytopathologic Diagnosis of Initially "Indeterminate" Pancreatic Mass Lesions.
    Janisch NH; Gordon SR; Gardner TB
    Pancreas; 2016 Aug; 45(7):e36-7. PubMed ID: 27400160
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of 22G fine-needle aspiration (FNA) versus fine-needle biopsy (FNB) for endoscopic ultrasound-guided sampling of pancreatic lesions: a prospective comparison study.
    Tian L; Tang AL; Zhang L; Liu XW; Li JB; Wang F; Shen SR; Wang XY
    Surg Endosc; 2018 Aug; 32(8):3533-3539. PubMed ID: 29404729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?
    Adişen E; Oztaş M; Gürer MA
    Dermatology; 2008; 216(2):163-5. PubMed ID: 18216480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum of the vulva treated with mycophenolate mofetil and infliximab.
    Sadowsky LM; Clark MA; Schlosser BJ
    Dermatol Ther; 2019 May; 32(3):e12905. PubMed ID: 30964575
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary pyoderma gangrenosum of the lungs.
    Kitagawa KH; Grassi M
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S114-6. PubMed ID: 19119117
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic gout and the role of multimodality imaging in its management.
    Koh H; Low HC; Seet JE; Chua WY
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27190122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual cause of a pancreatic mass.
    Sogabe Y; Yamamoto S; Kodama Y
    Gastrointest Endosc; 2018 Oct; 88(4):770-771. PubMed ID: 29908172
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab induces remission of pyoderma gangrenosum.
    Romero-Gómez M; Sánchez-Muñoz D
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):907. PubMed ID: 12172418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ultrasound-guided biopsy of the pancreas: a multicenter study].
    Garre Sánchez MC; Rendón Unceta P; López Cano A; Gómez Rubio M; de Cuenca Morón B; Segura Cabral JM; Crespo Sánchez M; Gil Grande LA; Varas Lorenzo MJ; Just Timoneda J; Gómez Rodríguez R; Galcera Tomás J; Abraldes Bechiarelli A; Macías Rodríguez M; Muñoz Benvenuty A; Tejada Cabrera M; Olveira A; Palacios Lázaro E
    Rev Esp Enferm Dig; 2007 Sep; 99(9):520-4. PubMed ID: 18052647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
    Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
    Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
    [No Abstract]   [Full Text] [Related]  

  • 15. Endoscopic ultrasound guided fine needle aspiration for diagnosis of pancreatic tuberculosis.
    Sharma V; Rana SS; Bhasin DK
    JOP; 2013 Sep; 14(5):521. PubMed ID: 24018601
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for peristomal pyoderma gangrenosum.
    Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
    Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.
    Ljung T; Staun M; Grove O; Fausa O; Vatn MH; Hellström PM
    Scand J Gastroenterol; 2002 Sep; 37(9):1108-10. PubMed ID: 12374238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of endoscopic ultrasound fine-needle aspiration in the diagnosis of solid pseudopapillary tumor of the pancreas: two case reports.
    De Moura DTH; Coronel M; Ribeiro IB; Farias GFA; Choez MA; Rocha R; Toscano MP; De Moura EGH
    J Med Case Rep; 2018 Apr; 12(1):107. PubMed ID: 29695287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy.
    Bobbitt SA; Klaus EM; Stringer E; Chowdhury D; Finlayson L
    Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.